PhRMA wins one in California

Share this article:
The Pharmaceutical Research and Manufacturers of America won a victory in last night's elections with the defeat of California Proposition 79, which would have imposed price controls on manufacturers participating in the state's Medi-Cal program and allowed individuals to sue companies for profiteering.
A rival ballot measure, the PhRMA-sponsored Proposition 78, was also voted down, 58-41 percent. PhRMA spent $72 million on an advertising, PR and direct-mail blitz to defeat Proposition 79, which lost by a margin of 61-38 percent. Backed by unions and consumer activists, the measure would have required drug companies to offer steep discounts to the uninsured in order to participate in Medi-Cal. By contrast, Proposition 78 would have encouraged companies to offer discounts voluntarily.
PhRMA's outlay on the campaign included $50 million in media spend and $13 million on glossy mailers, according to California press.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union